190 related articles for article (PubMed ID: 24141536)
1. Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.
Masui Y; Asano Y; Akamata K; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Rheumatol Int; 2014 Aug; 34(8):1165-70. PubMed ID: 24141536
[TBL] [Abstract][Full Text] [Related]
2. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis.
Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
J Dermatol; 2015 May; 42(5):461-6. PubMed ID: 25766303
[TBL] [Abstract][Full Text] [Related]
3. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin, resistin and TNF-α levels in patients with systemic sclerosis: the role of adipokines in scleroderma.
Pehlivan Y; Onat AM; Ceylan N; Turkbeyler IH; Buyukhatipoglu H; Comez G; Babacan T; Tarakcioglu M
Int J Rheum Dis; 2012 Aug; 15(4):374-9. PubMed ID: 22898217
[TBL] [Abstract][Full Text] [Related]
5. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.
Stochmal A; Czuwara J; Zaremba M; Rudnicka L
Arch Dermatol Res; 2020 Aug; 312(6):453-458. PubMed ID: 31667578
[TBL] [Abstract][Full Text] [Related]
6. Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.
Kawashiri SY; Nishino A; Igawa T; Takatani A; Shimizu T; Umeda M; Fukui S; Okada A; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakashima M; Mizokami A; Matsuoka N; Migita K; Ogawa F; Ikeda S; Maemura K; Nakamura H; Origuchi T; Maeda T; Kawakami A
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):102-108. PubMed ID: 29652651
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis.
Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Mod Rheumatol; 2012 Aug; 22(4):576-83. PubMed ID: 22075605
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
[TBL] [Abstract][Full Text] [Related]
9. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.
Assous N; Allanore Y; Batteux F; Meune C; Toulon P; Weill B; Kahan A
Clin Exp Rheumatol; 2005; 23(2):199-204. PubMed ID: 15895890
[TBL] [Abstract][Full Text] [Related]
11. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis.
Korman BD; Marangoni RG; Hinchcliff M; Shah SJ; Carns M; Hoffmann A; Ramsey-Goldman R; Varga J
Arthritis Rheumatol; 2017 Oct; 69(10):2062-2068. PubMed ID: 28651038
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
[TBL] [Abstract][Full Text] [Related]
14. Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis.
Ikawa T; Miyagawa T; Fukui Y; Minatsuki S; Maki H; Inaba T; Hatano M; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
Int J Rheum Dis; 2021 May; 24(5):711-718. PubMed ID: 33750014
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
[TBL] [Abstract][Full Text] [Related]
16. Resistin: a possible biomarker of organ involvement in systemic sclerosis patients?
Sawicka K; Michalska-Jakubus M; Kowal M; Potembska E; Krasowska D
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):144-150. PubMed ID: 28980898
[TBL] [Abstract][Full Text] [Related]
17. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
18. Serum level of circulating syndecan-1: A possible association with proliferative vasculopathy in systemic sclerosis.
Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
J Dermatol; 2016 Jan; 43(1):63-6. PubMed ID: 26076711
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Stefanantoni K; Sciarra I; Vasile M; Badagliacca R; Poscia R; Pendolino M; Alessandri C; Vizza CD; Valesini G; Riccieri V
Reumatismo; 2015 Mar; 66(4):270-6. PubMed ID: 25829187
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.
Lee YH; Song GG
Z Rheumatol; 2017 Nov; 76(9):789-797. PubMed ID: 27515182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]